P-2111 |
|
C35H67N17O11 |
902.03 |
81187-14-6 |
H-Arg-Lys-Arg-Ser-Arg-Ala-Glu-OH |
P-2112 |
|
C46H91N21O10 |
1098.36 |
152246-44-1 |
H-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-OH |
P-2113 |
Autocamtide-2 |
C65H118N22O20 |
1527.79 |
129198-88-5 |
H-Lys-Lys-Ala-Leu-Arg-Arg-Gln-Glu-Thr-Val-Asp-Ala-Leu-OH |
P-2114 |
Autocamtide-2-Related Inhibitory Peptide, AIP, (Ala9)-Autocamtide-2 |
C64H116N22O19 |
1497.76 |
167114-91-2 |
H-Lys-Lys-Ala-Leu-Arg-Arg-Gln-Glu-Ala-Val-Asp-Ala-Leu-OH |
P-2115 |
(Ala286)-Calmodulin-Dependent Protein Kinase II (281-302), (Ala286)-CaMK-II (281-302) |
C111H191N39O29S2 |
2600.12 |
141055-85-8 |
H-Met-His-Arg-Gln-Glu-Ala-Val-Asp-Cys-Leu-Lys-Lys-Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys-Gly-Ala-OH |
P-2116 |
Calmodulin-Dependent Protein Kinase II (281-309), CaMK-II (281-309) |
C146H254N46O39S3 |
3374.11 |
|
H-Met-His-Arg-Gln-Glu-Thr-Val-Asp-Cys-Leu-Lys-Lys-Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys-Gly-Ala-Ile-Leu-Thr-Thr-Met-Leu-Ala-OH |
P-2117 |
Calmodulin-Dependent Protein Kinase II (290-309) |
C103H185N31O24S |
2273.86 |
115044-69-4 |
H-Leu-Lys-Lys-Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys-Gly-Ala-Ile-Leu-Thr-Thr-Met-Leu-Ala-OH |
P-2118 |
cAMP-Dependent Protein Kinase Inhibitor-α (5-22) amide (human, mouse, rabbit, rat), PKI-α (5-22) amide (human, mouse, rabbit, rat), Wiptide |
C84H137N29O26 |
1969.19 |
100853-58-5 |
H-Thr-Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2 |
P-2119 |
cAMP-Dependent Protein Kinase Inhibitor-α (5-24) (human, mouse, rabbit, rat), PKI-α (5-24) (human, mouse, rabbit, rat), IP 20 |
C94H148N32O31 |
2222.41 |
99534-03-9 |
H-Thr-Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-His-Asp-OH |
P-2120 |
|
C32H49N6O10PS |
740.82 |
158778-21-3 |
Cyclo(-Gly-Tyr(PO3H2)-Val-Pro-Met-Leu) |
P-2121 |
Ephrin-A2-Selective YSA-Peptide, LERK-6-Selective YSA-Peptide, HEK7-L-Selective YSA-Peptide |
C59H86N12O20S2 |
1347.53 |
532441-10-4 |
H-Tyr-Ser-Ala-Tyr-Pro-Asp-Ser-Val-Pro-Met-Met-Ser-OH |
P-2122 |
|
C59H113N29O16 |
1484.73 |
102579-44-2 |
H-Gln-Arg-Arg-Gln-Arg-Lys-Ser-Arg-Arg-Thr-Ile-OH |
P-2123 |
|
C34H64N14O11 |
844.97 |
57836-10-9 |
H-Gly-Arg-Gly-Leu-Ser-Leu-Ser-Arg-OH |
P-2124 |
H1-7 |
C31H58N14O9 |
770.89 |
65189-70-0 |
H-Arg-Arg-Lys-Ala-Ser-Gly-Pro-OH |
P-2125 |
|
C101H172N30O32 |
2318.66 |
137348-21-1 |
H-Lys-Arg-Glu-Leu-Val-Glu-Pro-Leu-Thr-Pro-Ser-Gly-Glu-Ala-Pro-Asn-Gln-Ala-Leu-Leu-Arg-OH |
P-2126 |
|
C28H56N12O7 |
672.83 |
121145-48-0 |
H-Lys-Arg-Thr-Leu-Arg-OH |
P-2127 |
Malantide |
C72H124N22O21 |
1633.91 |
86555-35-3 |
H-Arg-Thr-Lys-Arg-Ser-Gly-Ser-Val-Tyr-Glu-Pro-Leu-Lys-Ile-OH |
P-2128 |
MAPKK2 (1-16) (human, mouse, rat), Dual Specifity Mitogen-Activated Protein Kinase Kinase 2 (1-16) (human, mouse, rat), MAP Kinase Kinase 2 (1-16) (human, mouse, rat), MEK2 (1-16) (human, mouse, rat), ERK Activator Kinase 2 (1-16) (human, mouse, rat), MAPK/ERK Kinase 2 (1-16) (human, mouse, rat) |
C81H144N24O19S |
1790.25 |
496957-39-2 |
H-Met-Leu-Ala-Arg-Arg-Lys-Pro-Val-Leu-Pro-Ala-Leu-Thr-Ile-Asn-Pro-OH |
P-2129 |
|
C60H117N21O11 |
1308.72 |
152246-40-7 |
Myristoyl-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-OH |
P-2130 |
|
C42H82N12O8 |
883.19 |
125678-68-4 |
Myristoyl-Lys-Arg-Thr-Leu-Arg-OH |
P-2131 |
|
C60H105N17O12 |
1256.6 |
147217-25-2 |
Myristoyl-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-OH |
P-2132 |
Neurogranin (30-45) (human) |
C78H134N28O19S |
1800.17 |
146554-17-8 |
H-Ala-Ala-Lys-Ile-Gln-Ala-Ser-Phe-Arg-Gly-His-Met-Ala-Arg-Lys-Lys-OH |
P-2133 |
p60 v-src (137-157) |
C111H168N30O35 |
2482.74 |
131023-24-0 |
H-Val-Ala-Pro-Ser-Asp-Ser-Ile-Gln-Ala-Glu-Glu-Trp-Tyr-Phe-Gly-Lys-Ile-Thr-Arg-Arg-Glu-OH |
P-2134 |
Peptide ε |
C83H155N39O21S |
2067.46 |
120253-69-2 |
H-Glu-Arg-Met-Arg-Pro-Arg-Lys-Arg-Gln-Gly-Ser-Val-Arg-Arg-Arg-Val-OH |
P-2135 |
|
C46H79N17O11 |
1046.24 |
150626-45-2 |
H-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-OH |
P-2136 |
|
C45H73N11O8 |
896.14 |
137168-33-3 |
H-Phe-Lys-Lys-Ser-Phe-Lys-Leu-NH2 |
P-2137 |
Phosphorylase Kinase β-Subunit Fragment (420-436) |
C79H131N31O25S |
1947.18 |
150829-21-3 |
H-Lys-Arg-Asn-Pro-Gly-Ser-Gln-Lys-Arg-Phe-Pro-Ser-Asn-Cys-Gly-Arg-Asp-OH |
P-2138 |
PKI-tide |
C85H149N31O24 |
1989.31 |
126370-52-3 |
H-Ile-Ala-Ala-Gly-Arg-Thr-Gly-Arg-Arg-Gln-Ala-Ile-His-Asp-Ile-Leu-Val-Ala-Ala-OH |
P-2139 |
pp60 c-src (521-533) |
C62H94N16O25 |
1463.52 |
198754-34-6 |
H-Thr-Ser-Thr-Glu-Pro-Gln-Tyr-Gln-Pro-Gly-Glu-Asn-Leu-OH |
P-2140 |
pp60 c-src (521-533) (phosphorylated) |
C62H95N16O28P |
1543.5 |
149299-77-4 |
H-Thr-Ser-Thr-Glu-Pro-Gln-Tyr(PO3H2)-Gln-Pro-Gly-Glu-Asn-Leu-OH |
P-2141 |
|
C56H103N17O16 |
1270.54 |
105802-84-4 |
H-Pro-Leu-Ser-Arg-Thr-Leu-Ser-Val-Ala-Ala-Lys-Lys-OH |
P-2142 |
Protein Kinase C (19-31) |
C67H118N26O16 |
1543.84 |
121545-65-1 |
H-Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-Lys-Asn-Val-OH |
P-2143 |
(Ser25)-Protein Kinase C (19-31) |
C67H118N26O17 |
1559.84 |
136795-05-6 |
H-Arg-Phe-Ala-Arg-Lys-Gly-Ser-Leu-Arg-Gln-Lys-Asn-Val-OH |
P-2144 |
Protein Kinase C (19-36) |
C93H159N35O24 |
2151.51 |
113731-96-7 |
H-Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-Lys-Asn-Val-His-Glu-Val-Lys-Asn-OH |
P-2145 |
Protein Kinase C (530-558) |
C148H221N35O50S2 |
3354.72 |
122613-29-0 |
H-Leu-Leu-Tyr-Glu-Met-Leu-Ala-Gly-Gln-Ala-Pro-Phe-Glu-Gly-Glu-Asp-Glu-Asp-Glu-Leu-Phe-Gln-Ser-Ile-Met-Glu-His-Asn-Val-NH2 |
P-2146 |
SAMS Peptide, (Ser77,Arg87·88)-ACC-α (74-88) (dephosphorylated) (bovine, ovine), (Ser76,Arg86·87)-ACC-α (73-87) (dephosphorylated) (E. coli, rat), (Ser77,Arg87·88)-Acetyl-CoA Carboxylase 1 (74-88) (dephosphorylated) (bovine, ovine), (Ser76,Arg86·87)-Acetyl-CoA Carboxylase 1 (73-87) (dephosphorylated) (E. coli, rat) |
C74H131N29O18S2 |
1779.17 |
125911-68-4 |
H-His-Met-Arg-Ser-Ala-Met-Ser-Gly-Leu-His-Leu-Val-Lys-Arg-Arg-OH |
P-2147 |
Syntide 2, Calmodulin-Dependent Protein Kinase Substrate |
C68H122N20O18 |
1507.84 |
108334-68-5 |
H-Pro-Leu-Ala-Arg-Thr-Leu-Ser-Val-Ala-Gly-Leu-Pro-Gly-Lys-Lys-OH |
P-2148 |
|
C121H164N32O27S |
2530.89 |
175799-54-9 |
H-Tyr-Ser-Phe-Val-His-His-Gly-Phe-Phe-Asn-Phe-Arg-Val-Ser-Trp-Arg-Glu-Met-Leu-Ala-OH |
P-2149 |
VRKRTLRRL |
C51H100N22O11 |
1197.5 |
105802-82-2 |
H-Val-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu-OH |
P-2150 |
VEGFR-KDR/Flk-1 Antagonist Peptide, K237 |
C77H99N23O18S |
1666.84 |
492444-99-2 |
H-His-Thr-Met-Tyr-Tyr-His-His-Tyr-Gln-His-His-Leu-OH |
P-2201 |
Pseudin-2 |
C122H202N36O32 |
2685.17 |
|
H-Gly-Leu-Asn-Ala-Leu-Lys-Lys-Val-Phe-Gln-Gly-Ile-His-Glu-Ala-Ile-Lys-Leu-Ile-Asn-Asn-His-Val-Gln-OH |
P-2201-2 |
(Lys18)-Pseudin-2 |
C122H203N37O32 |
2700.18 |
|
H-Gly-Leu-Asn-Ala-Leu-Lys-Lys-Val-Phe-Gln-Gly-Ile-His-Glu-Ala-Ile-Lys-Lys-Ile-Asn-Asn-His-Val-Gln-OH |
P-2301 |
pTH-Related Protein (1-16) (human, mouse, rat), Hypercalcemia of Malignancy Factor (1-16) (human, mouse, rat) |
C77H128N24O25 |
1790.01 |
126391-27-3 |
H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-OH |
P-2302 |
pTH-Related Protein (1-34) (human, mouse, rat), Hypercalcemia of Malignancy Factor (1-34) (human, mouse, rat), pTHrP (1-34) (human, mouse, rat) |
C180H287N57O48 |
4017.61 |
112540-82-6 |
H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-OH |
P-2302-2 |
Biotinyl-pTH-Related Protein (1-34) (human, mouse, rat), Biotinyl-Hypercalcemia of Malignancy Factor (1-34) (human, mouse, rat), Biotinyl-pTHrP (1-34) (human, mouse, rat) |
C190H301N59O50S |
4243.91 |
|
Biotinyl-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-OH |
P-2302-3 |
(Tyr0)-pTH-Related Protein (1-34) (human, mouse, rat), (Tyr0)-Hypercalcemia of Malignancy Factor (1-34) (human, mouse, rat) |
C189H296N58O50 |
4180.79 |
|
H-Tyr-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-OH |
P-2302-4 |
pTH-Related Protein (1-34) amide (human, mouse, rat), Hypercalcemia of Malignancy Factor (1-34) amide (human, mouse, rat), pTHrP (1-34) amide (human, mouse, rat) |
C180H288N58O47 |
4016.63 |
112955-31-4 |
H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH2 |
P-2303 |
(Ile5,Trp23,Tyr36)-pTH-Related Protein (1-36) (human, mouse, rat), (Ile5,Trp23,Tyr36)-Hypercalcemia of Malignancy Factor (1-36) (human, mouse, rat), (Ile5,Trp23,Tyr36)-pTHrP (1-36) (human, mouse, rat) |
C196H308N58O53 |
4324.96 |
181057-31-8 |
H-Ala-Val-Ser-Glu-Ile-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Trp-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Tyr-OH |
P-2303-2 |
(Tyr36)-pTH-Related Protein (1-36) (human, mouse, rat), (Tyr36)-Hypercalcemia of Malignancy Factor (1-36) (human, mouse, rat) |
C194H303N59O53 |
4309.91 |
213779-11-4 |
H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Tyr-OH |
P-2304 |
(Tyr36)-pTH-Related Protein (1-36) amide (chicken), (Tyr36)-Hypercalcemia of Malignancy Factor (1-36) amide (chicken), (Tyr36)-pTHrp (1-36) amide (chicken) |
C184H301N57O55 |
4191.76 |
152617-91-9 |
H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Ile-Phe-Leu-Gln-Asn-Leu-Ile-Glu-Gly-Val-Asn-Thr-Ala-Glu-Tyr-NH2 |